Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxidized phospholipid degradation is the process by which the body breaks down oxidized phospholipids (OxPLs), a diverse group of bioactive lipids formed by oxidative modification of phospholipids. This degradation is crucial for detoxifying pro-inflammatory lipid mediators, regulating immune responses, and preventing the accumulation of OxPLs implicated in diseases like atherosclerosis and chronic inflammation. Key enzymes involved include Lp-PLA₂, Platelet activating factor-acetylhydrolase, Lysosomal PLA₂, Aldoketoreductases, and Aldehyde dehydrogenases. The balance between OxPL formation and degradation is critical for maintaining health.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxidized Phospholipid Degradation.